Piramal Enterprises Ltd Performance
Open
820
Traded Value (Cr)
63.74 Cr
Prev. Close
815.8
VWAP
840.43
Volume
55,91,615
Face Value
2
Piramal Enterprises Ltd Fundamentals
Piramal Enterprises Ltd F&O
Piramal Enterprises Ltd Financials
Resistance and Support
₹934.15
PIVOT
 Resistance | |
|---|---|
| First Resistance | ₹951.700 |
| Second Resistance | ₹974.650 |
| Third Resistance | ₹992.200 |
 Support | |
|---|---|
| First Resistance | ₹911.200 |
| Second Resistance | ₹893.650 |
| Third Resistance | ₹870.700 |
| RSI | 45.544 |
| MACD | 37.905 |
| ADX | 27.783 |
| CCI | -97.845 |
Delivery and Volume
About Piramal Enterprises Ltd
Piramal Enterprises Limited is a global Indian corporation that offers medicines and financial services. It is based in Mumbai, Maharashtra. The company was founded by Ajay Piramal, who also serves as Chairman and is involved in the financial services, real estate, and pharmaceutical industries. In 1984, he started the business after buying his father's small-scale manufacturing facility. Currently, Piramal employs over 10,000 people worldwide and operates more than 50 offices in 30 different countries. It is also present via its affiliates or subsidiaries in more than 100 countries. In 2019, Forbes Asia listed Piramal as one of the 200 Best Under A Billion. You can keep an eye on Piramal Enterprises Ltd on NSE & BSE daily for better insights. Piramal Enterprises Limited (PEL) is a non-banking financial corporation in India, part of the Piramal Group, which operates in various sectors including healthcare, life sciences, drug discovery, financial services, alternative investments, and real estate. Ajay Piramal took over leadership in the early 1980s and acquired Gujarat Glass Limited in 1984. In 1988, the group acquired Nicholas Laboratories, which became highly valued in the pharmaceutical industry by 2010. In 2006, the group acquired Pfizer's UK manufacturing facility in Morpeth and established the Piramal Foundation. In 2007, the group entered into a significant deal with Merck Pharmaceuticals for drug development and discovery, and in 2008, another deal with Eli Lilly and Company. In 2010, Piramal Healthcare sold its domestic formulations business to Abbott for a substantial sum, divested its diagnostics chain to SRL, and ventured into real estate with Piramal Realty. In 2012, Piramal Enterprises Ltd was renamed. Piramal's bio-orthopedic product, BST-CarGel, received European CE mark approval, and its Decision Resources Group acquired UK-based Abacus International. Keep an eye on Piramal share price for better insights. Ajay Piramal, Chairman Chairman of the Piramal Group, a multinational conglomerate with interests in pharmaceuticals, financial services, and real estate, is Ajay Piramal, an Indian industrialist and philanthropist. With products distributed in more than 100 markets, the group operates in more than 30 countries. The Piramal Group, well-known for its long-lasting alliances with prestigious international investors, is dedicated to encouraging ethical entrepreneurship and building enduring value for its stakeholders and the larger community. He is a fervent advocate of social entrepreneurship and is deeply committed to using the Piramal Foundation to realize India's socio-economic potential. Checkout Piramal Enterprises Ltd share price with BlinkX.Piramal Enterprises Share Price Today
History of Piramal Enterprises
Key Personnel of Piramal Enterprises
Managing Director
Founded
1947
NSE Symbol
PEL
Piramal Enterprises Ltd Management
| Name | Designation |
|---|---|
| Ajay G Piramal | Chairman & Exec. Director |
| Swati A Piramal | Vice Chairperson |
| Nandini Piramal | Executive Director |
| S Rama Dorai | Independent Director |
| Anand Piramal | Non Executive Director |
| Bipin Singh | Company Sec. & Compli. Officer |
| Vijay Shah | Non Executive Director |
| Suhail Nathani | Independent Director |
| KUNAL BAHL | Independent Director |
| Anjali Bansal | Independent Director |
| Shikha Sharma | Non Executive Director |
| Puneet Yadu Dalmia | Independent Director |
| Anita M George | Independent Director |
| Rajiv Mehrishi. | Independent Director |
| Gautam Doshi | Independent Director |
Piramal Enterprises Ltd News
Similar Stocks
| Company | Market Cap | Market Price | P/E Ratio |
|---|---|---|---|
| BAJFINANCE | ₹ 4,08,856 Cr | ₹ 6,632.15 (0.41 %) | 32.34 |
| BAJAJFINSV | ₹ 2,49,630 Cr | ₹ 1,566.25 (0.11 %) | 213.25 |
| JIOFIN | ₹ 2,19,442 Cr | ₹ 341.80 (-1.04 %) | 0.00 |
| IRFC | ₹ 1,92,172 Cr | ₹ 147.00 (-0.03 %) | 31.80 |
| PFC | ₹ 1,37,960 Cr | ₹ 419.50 (0.35 %) | 10.05 |